Today on MedNet21, we're going to discuss Gender Affirming Care.
Using 2 patient cases, we will walk through how to begin hormone therapy for gender affirmation. This will include a brief overview of the risks, benefits, side effects and prescribing considerations for both feminizing and masculinizing cross-sex hormone therapy.
Learners will understand the difference between Sex and Gender, and learn about disparities that transgender and gender diverse persons face in healthcare.
Dates and Times
End Date: 10/7/2025
Gender Affirming Care
As a result of this educational activity, webcast participants will be able to:
- Review feminizing gender affirming hormone therapy including types of medications used, contraindications, risks, and benefits of treatment.
- Review masculinizing hormone therapy including contraindications, risks, and benefits of treatment and how this treatment may differ for non-binary individuals.
the difference between Sex and Gender
- Learn to create a safe, supportive space for gender diverse individuals
The Center for Continuing Medical Education (CCME) at The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians
The Center for Continuing Medical Education (CCME) at The Ohio State University designates this webcasts for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Maintenance of Certification
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.